vs

Side-by-side financial comparison of ACACIA RESEARCH CORP (ACTG) and RIGEL PHARMACEUTICALS INC (RIGL). Click either name above to swap in a different company.

RIGEL PHARMACEUTICALS INC is the larger business by last-quarter revenue ($69.8M vs $50.1M, roughly 1.4× ACACIA RESEARCH CORP). RIGEL PHARMACEUTICALS INC runs the higher net margin — 384.0% vs 6.8%, a 377.2% gap on every dollar of revenue. On growth, RIGEL PHARMACEUTICALS INC posted the faster year-over-year revenue change (21.2% vs 2.6%). Over the past eight quarters, RIGEL PHARMACEUTICALS INC's revenue compounded faster (53.7% CAGR vs 43.6%).

Acacia Research Corporation is a publicly traded American company based in New York City. It acquires and operates businesses in industries including the technology, energy, and industrial/manufacturing sectors. Acacia has a strategic relationship with Starboard Value, LP, the company's controlling shareholder. The company has been characterized as a patent troll.

Rigel Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing targeted small molecule therapies for autoimmune, inflammatory, and hematologic diseases. Its approved flagship product treats adult immune thrombocytopenia, with primary operations and core markets in the United States, addressing unmet medical needs for underserved patient groups.

ACTG vs RIGL — Head-to-Head

Bigger by revenue
RIGL
RIGL
1.4× larger
RIGL
$69.8M
$50.1M
ACTG
Growing faster (revenue YoY)
RIGL
RIGL
+18.6% gap
RIGL
21.2%
2.6%
ACTG
Higher net margin
RIGL
RIGL
377.2% more per $
RIGL
384.0%
6.8%
ACTG
Faster 2-yr revenue CAGR
RIGL
RIGL
Annualised
RIGL
53.7%
43.6%
ACTG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACTG
ACTG
RIGL
RIGL
Revenue
$50.1M
$69.8M
Net Profit
$3.4M
$268.1M
Gross Margin
12.8%
91.5%
Operating Margin
-26.1%
33.2%
Net Margin
6.8%
384.0%
Revenue YoY
2.6%
21.2%
Net Profit YoY
125.5%
1769.2%
EPS (diluted)
$0.03
$14.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACTG
ACTG
RIGL
RIGL
Q4 25
$50.1M
$69.8M
Q3 25
$59.4M
$69.5M
Q2 25
$51.2M
$101.7M
Q1 25
$124.4M
$53.3M
Q4 24
$48.8M
$57.6M
Q3 24
$23.3M
$55.3M
Q2 24
$25.8M
$36.8M
Q1 24
$24.3M
$29.5M
Net Profit
ACTG
ACTG
RIGL
RIGL
Q4 25
$3.4M
$268.1M
Q3 25
$-2.7M
$27.9M
Q2 25
$-3.3M
$59.6M
Q1 25
$24.3M
$11.4M
Q4 24
$-13.4M
$14.3M
Q3 24
$-14.0M
$12.4M
Q2 24
$-8.4M
$-1.0M
Q1 24
$-186.0K
$-8.2M
Gross Margin
ACTG
ACTG
RIGL
RIGL
Q4 25
12.8%
91.5%
Q3 25
21.2%
93.2%
Q2 25
12.8%
95.6%
Q1 25
47.4%
91.7%
Q4 24
17.6%
89.9%
Q3 24
10.1%
85.5%
Q2 24
26.2%
92.4%
Q1 24
49.2%
93.1%
Operating Margin
ACTG
ACTG
RIGL
RIGL
Q4 25
-26.1%
33.2%
Q3 25
-10.8%
40.9%
Q2 25
-24.2%
60.1%
Q1 25
30.8%
23.9%
Q4 24
-32.4%
28.9%
Q3 24
-44.1%
25.4%
Q2 24
-18.4%
1.2%
Q1 24
-8.6%
-23.6%
Net Margin
ACTG
ACTG
RIGL
RIGL
Q4 25
6.8%
384.0%
Q3 25
-4.6%
40.2%
Q2 25
-6.4%
58.6%
Q1 25
19.5%
21.5%
Q4 24
-27.5%
24.9%
Q3 24
-60.0%
22.5%
Q2 24
-32.7%
-2.8%
Q1 24
-0.8%
-27.9%
EPS (diluted)
ACTG
ACTG
RIGL
RIGL
Q4 25
$0.03
$14.11
Q3 25
$-0.03
$1.46
Q2 25
$-0.03
$3.28
Q1 25
$0.25
$0.63
Q4 24
$-0.14
$0.82
Q3 24
$-0.14
$0.70
Q2 24
$-0.08
$-0.06
Q1 24
$0.00
$-0.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACTG
ACTG
RIGL
RIGL
Cash + ST InvestmentsLiquidity on hand
$306.7M
$155.0M
Total DebtLower is stronger
$91.9M
$52.5M
Stockholders' EquityBook value
$543.5M
$391.5M
Total Assets
$771.0M
$513.6M
Debt / EquityLower = less leverage
0.17×
0.13×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACTG
ACTG
RIGL
RIGL
Q4 25
$306.7M
$155.0M
Q3 25
$301.8M
$137.1M
Q2 25
$316.7M
$108.4M
Q1 25
$272.0M
$77.1M
Q4 24
$273.9M
$77.3M
Q3 24
$410.9M
$61.1M
Q2 24
$441.9M
$49.1M
Q1 24
$498.4M
$49.5M
Total Debt
ACTG
ACTG
RIGL
RIGL
Q4 25
$91.9M
$52.5M
Q3 25
$60.0M
Q2 25
$60.0M
Q1 25
$60.0M
Q4 24
$60.0M
Q3 24
$60.0M
Q2 24
$60.0M
Q1 24
$60.0M
Stockholders' Equity
ACTG
ACTG
RIGL
RIGL
Q4 25
$543.5M
$391.5M
Q3 25
$537.6M
$117.6M
Q2 25
$538.6M
$81.9M
Q1 25
$540.2M
$18.6M
Q4 24
$514.8M
$3.3M
Q3 24
$540.2M
$-14.6M
Q2 24
$560.7M
$-29.9M
Q1 24
$568.3M
$-31.7M
Total Assets
ACTG
ACTG
RIGL
RIGL
Q4 25
$771.0M
$513.6M
Q3 25
$768.9M
$242.5M
Q2 25
$775.5M
$206.7M
Q1 25
$801.6M
$176.0M
Q4 24
$756.4M
$164.0M
Q3 24
$707.6M
$139.4M
Q2 24
$753.6M
$128.4M
Q1 24
$631.7M
$126.5M
Debt / Equity
ACTG
ACTG
RIGL
RIGL
Q4 25
0.17×
0.13×
Q3 25
0.51×
Q2 25
0.73×
Q1 25
3.23×
Q4 24
18.25×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACTG
ACTG
RIGL
RIGL
Operating Cash FlowLast quarter
$75.2M
$22.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
22.01×
0.08×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACTG
ACTG
RIGL
RIGL
Q4 25
$75.2M
$22.0M
Q3 25
$9.5M
$24.0M
Q2 25
$50.1M
$30.5M
Q1 25
$2.4M
$-893.0K
Q4 24
$50.1M
$14.5M
Q3 24
$-593.0K
$21.7M
Q2 24
$16.1M
$302.0K
Q1 24
$54.8M
$-5.0M
Free Cash Flow
ACTG
ACTG
RIGL
RIGL
Q4 25
Q3 25
Q2 25
Q1 25
$335.0K
Q4 24
$-98.5M
Q3 24
$-2.8M
Q2 24
$-126.7M
Q1 24
$54.6M
FCF Margin
ACTG
ACTG
RIGL
RIGL
Q4 25
Q3 25
Q2 25
Q1 25
0.3%
Q4 24
-201.8%
Q3 24
-12.1%
Q2 24
-490.5%
Q1 24
224.4%
Capex Intensity
ACTG
ACTG
RIGL
RIGL
Q4 25
Q3 25
Q2 25
Q1 25
1.7%
Q4 24
304.4%
Q3 24
9.6%
Q2 24
553.0%
Q1 24
1.1%
Cash Conversion
ACTG
ACTG
RIGL
RIGL
Q4 25
22.01×
0.08×
Q3 25
0.86×
Q2 25
0.51×
Q1 25
0.10×
-0.08×
Q4 24
1.01×
Q3 24
1.75×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACTG
ACTG

Energy Operations$16.0M32%
Transportation Safety$10.4M21%
Office Storage And Display Solutions$8.4M17%
Printers Consumables And Parts$6.5M13%
Natural Gas Reserves$5.1M10%
Natural Gas Liquids Reserves$3.3M7%

RIGL
RIGL

Segment breakdown not available.

Related Comparisons